Ongoing disease-activity and change in ILAR categories in a Nordic juvenile idiopathic arthritis cohort

Ellen Nordal,Marek Zak,Suvi Peltoniemi,Troels Herlin,Pekka Lahdenne,Bjørn Straume,Lillemor Berntson,Anders Fasth,Susan Nielsen,Kristiina Aalto,Marite Rygg

doi:10.1186/1546-0096-10-s1-a41

Abstract

Purpose Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. During the last decade international consensus on the ILAR (International League Against Rheumatism) classification of this heterogeneous group of chronic childhood arthritis has been reached. In an era of modern medical treatment, epidemiologic studies on outcome in unselected cohorts of children with JIA are important. The aim of the study was to describe disease characteristics, ILAR categories and remission status during the first eight years after disease onset in a cohort of Nordic children with JIA in a population-based setting.

Highlights

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children
From 2011 Pediatric Rheumatology Symposium sponsored by the American College of Rheumatology Miami, FL, USA. 2-5 June 2011
The aim of the study was to describe disease characteristics, ILAR categories and remission status during the first eight years after disease onset in a cohort of Nordic children with JIA in a population-based setting

Summary

Open Access

Ellen Nordal6*, Marek Zak, Lillemor Berntson, Kristiina Aalto, Suvi Peltoniemi, Susan Nielsen, Troels Herlin, Pekka Lahdenne, Bjørn Straume, Anders Fasth, Marite Rygg. From 2011 Pediatric Rheumatology Symposium sponsored by the American College of Rheumatology Miami, FL, USA. Purpose Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. During the last decade international consensus on the ILAR (International League Against Rheumatism) classification of this heterogeneous group of chronic childhood arthritis has been reached. In an era of modern medical treatment, epidemiologic studies on outcome in unselected cohorts of children with JIA are important. The aim of the study was to describe disease characteristics, ILAR categories and remission status during the first eight years after disease onset in a cohort of Nordic children with JIA in a population-based setting

Methods

Results

Conclusion